Article
CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Jun 2008
Jones Terreia S, Kaste Sue C, Liu Wei, Cheng Cheng, Yang Wenjian, Tantisira Kelan G, Pui Ching-Hon, Relling Mary V
Abstract excerpt
PURPOSE: Corticosteroids are a critical component of therapy for acute lymphoblastic leukemia (ALL) but are associated with late effects, such as osteoporosis. Risk factors remain poorly defined. Because CRHR1 polymorphisms have been associated with other corticosteroid effects, our goal was to d...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
